S-CELLERATE

Serial Number 79339661
Registration 7490485
700

Registration Progress

Application Filed
Jan 25, 2022
Under Examination
Approved for Publication
Jun 18, 2024
Published for Opposition
Jun 18, 2024
Registered
Sep 3, 2024

Trademark Image

S-CELLERATE

Basic Information

Serial Number
79339661
Registration Number
7490485
Filing Date
January 25, 2022
Registration Date
September 3, 2024
Published for Opposition
June 18, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 3, 2024
Registration
Registered
Classes
040 042

Rights Holder

Samsung Biologics Co., Ltd.

03
Address
300, Songdo bio-daero,
Yeonsu-gu Incheon
KR

Ownership History

Samsung Biologics Co., Ltd.

Original Applicant
03
KR

Samsung Biologics Co., Ltd.

Owner at Publication
03
KR

Samsung Biologics Co., Ltd.

Original Registrant
03
KR

Legal Representation

Attorney
Lisa C. Pavento

USPTO Deadlines

Next Deadline
1862 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-09-03)
Due Date
September 03, 2030
Grace Period Ends
March 03, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

30 events
Date Code Type Description Documents
Mar 8, 2025 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Feb 16, 2025 FIMP P FINAL DISPOSITION PROCESSED Loading...
Feb 16, 2025 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Dec 3, 2024 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Sep 3, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Sep 3, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 1, 2024 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Jun 18, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 18, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 11, 2024 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Jun 11, 2024 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
May 29, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 16, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 1, 2024 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Dec 13, 2023 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Dec 13, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Jun 22, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 21, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 21, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 14, 2023 RFNT P REFUSAL PROCESSED BY IB Loading...
Jan 23, 2023 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Jan 23, 2023 RFRR P REFUSAL PROCESSED BY MPU Loading...
Nov 17, 2022 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Nov 16, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 4, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 6, 2022 CORR I CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED Loading...
Jul 10, 2022 CRCV M CORRECTION TRANSACTION RECEIVED FROM IB Loading...
May 10, 2022 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
May 6, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 5, 2022 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 040
Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials; custom manufacture of biopharmaceutical materials with generation of cell line; chemical treatment of liquids; processing of medicinal materials; custom manufacture of pharmaceuticals; processing of pharmaceutical preparations; preservation of pharmaceuticals; processing of medical products; processing of chemicals
Class 042
Medical research in the field of crude drugs; development of cell therapy products; development of pharmaceutical preparations and medicines; drug development; inspection of pharmaceuticals; research of pharmaceuticals; clinical testing of medicines; pharmaceutical products evaluation; research of medical products; bacteriological research and analysis; medical laboratory services; stem cell research services; scientific research in the nature of conducting clinical trials; medicine research; research and development of technology for biotechnology; microbial testing for scientific research purposes; biochemistry research services; scientific research in the field of genetics; scientific research in the field of genetic engineering

Classification

International Classes
040 042